The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 09, 2019
Filed:
Apr. 15, 2016
Applicant:
Randox Laboratories Limited, Crumlin, Antrim, GB;
Inventors:
Elouard Benchikh, Crumlin, GB;
Ivan McConnell, Crumlin, GB;
Philip Lowry, Crumlin, GB;
Peter Fitzgerald, Crumlin, GB;
Assignee:
Randox Laboratories Limited, , GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 295/155 (2006.01); G01N 33/53 (2006.01); C07K 14/47 (2006.01); C07K 14/765 (2006.01); C07K 16/44 (2006.01); C07D 295/096 (2006.01); C07D 241/04 (2006.01);
U.S. Cl.
CPC ...
C07D 295/155 (2013.01); C07D 241/04 (2013.01); C07D 295/096 (2013.01); C07K 14/47 (2013.01); C07K 14/765 (2013.01); C07K 16/44 (2013.01); G01N 33/5308 (2013.01); C07K 2317/76 (2013.01);
Abstract
The current invention describes novel immunogens which are used in the production of novel antibodies with unique binding properties in that they cross-react with a variety of phenylpiperazine derivatives. These antibodies enable methods and kits to detect and/or determine phenylpiperazine derivatives (for example mCPP, TFMPP and MeOPP) in an in vitro sample which are advantageous over currently available analytical methods in terms of cost, ease of use, speed and sensitivity.